CD8⁺ lymphocyte control of SIV infection during antiretroviral therapy

Journal Article · 10 October 2018 · PLoS Pathogens

DOI: https://doi.org/10.1371/journal.ppat.1007350 · OSTI ID:1484641

Cao, Youfang  ^[1]; Cartwright, Emily ^[2]; Silvestri, Guido ^[2]; Perelson, Alan S.  ^[1]

---

1. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
2. Emory Univ., Atlanta, GA (United States)

CD8⁺ lymphocytes play an important role in suppressing in vivo viral replication in HIV infection. However, both the extent to which and the mechanisms by which CD8⁺ lymphocytes contribute to viral control are not completely understood. A recent experiment depleted CD8⁺ lymphocytes in simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) on antiretroviral treatment (ART) to study the role of CD8⁺ lymphocytes. CD8⁺ lymphocytes depletion resulted in temporary plasma viremia in all studied RMs. Viral control was restored when CD8⁺ lymphocytes repopulated. We developed a viral dynamic model to fit the viral load (VL) data from the CD8 depletion experiment. We explicitly modeled the dynamics of the latent reservoir and the SIV-specific effector cell population including their exhaustion and their potential cytolytic and noncytolytic functions. We found that the latent reservoir significantly contributes to the size of the peak VL after CD8 depletion, while drug efficacy plays a lesser role. Our model suggests that the overall CD8⁺ lymphocyte cytolytic killing rate is dynamically changing depending on the levels of antigen-induced effector cell activation and exhaustion. Based on estimated parameters, our model suggests that before ART or without ART the overall CD8 cytolytic killing rate is small due to exhaustion. However, after the start of ART, the overall CD8 cytolytic killing rate increases due to an expansion of SIV-specific CD8 effector cells. Further, we estimate that the cytolytic killing rate can be significantly larger than the cytopathic death rate in some animals during the second phase of ART-induced viral decay. Lastly, our model provides a new explanation for the puzzling findings by Klatt et al. and Wong et al. that CD8 depletion done immediately before ART has no noticeable effect on the first phase viral decay slope seen after ART initiation Overall, by incorporating effector cells and their exhaustion, our model can explain the effects of CD8 depletion on VL during ART, reveals a detailed dynamic role of CD8⁺ lymphocytes in controlling viral infection, and provides a unified explanation for CD8 depletion experimental data.

• Research Organization: Los Alamos National Laboratory (LANL)
• Sponsoring Organization: National Institutes of Health (NIH); USDOE
• Grant/Contract Number: 89233218CNA000001; AC52-06NA25396
• OSTI ID: 1484641
• Report Number(s): LA-UR-18-22077
• Journal Information: PLoS Pathogens, Journal Name: PLoS Pathogens Journal Issue: 10 Vol. 14; ISSN 1553-7374
• Publisher: Public Library of ScienceCopyright Statement
• Country of Publication: United States
• Language: English